rhPTH(1-34) recombinant human
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for rhPTH(1-34) recombinant human, covering 2021-06-28 to 2021-06-28. Get the full timeline:
Most recent: Clinical Trial Update: Recombinant Human rhPTH(1-34) VS Association Alfacalcidol/Hydrochlorothiazide in Severe Primary Hypoparathyroidism [Phase 2]